The board of directors of JMI Syringes & Medical Devices Limited has recommended 30 per cent cash dividend for the year ended on June 30, 2017, said an official disclosure on Wednesday.
The final approval of dividend will come during the Annual General Meeting (AGM) scheduled to be held on December 30 at 11:00am in Dhaka.
The record date for entitlement of dividend is on October 31, 2017.
The company has also reported earnings per share (EPS) of Tk 6.78, net asset value per share (NAV) per share of Tk 67.64 and net operating cash flow per share (NOCFPS) of Tk 13.97 for the year ended on June 30, 2017 as against Tk. 6.43, Tk. 64.63 and Tk. 32.09 respectively for the same period of the previous year.
In 2016, the company disbursed 35 per cent cash dividend.
There will be no price limit on the trading of the shares of the company today (Wednesday) following its corporate declaration.
Each share of the company, which was listed with the Dhaka bourse in 2013, closed at Tk 187.90 on Tuesday at Dhaka Stock Exchange (DSE).
The company’s paid-up capital is Tk 110 million and authorised capital is Tk 1.0 million while total number of securities is 11 million.
The sponsor-directors own 49.31 per cent stake in the company, institutional investors own 8.75 per cent, foreign 12.73 per cent and the general public own 29.21 per cent as on September 30, 2017, the DSE data shows.
